Articles by Disease (Sarcoma)

MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 5
Page: 27-41
Author(s): Elizabeth Rayburn, Ruiwen Zhang, Jie He and Hui Wang

Chemosensitization by Antisense Oligonucleotides Targeting MDM2

Journal: Current Cancer Drug Targets
Volume: 5
Page: 51-56
Author(s): Roberto Bianco, Fortunato Ciardiello and Giampaolo Tortora

Nanotechnology on Duty in Medical Applications

Journal: Current Pharmaceutical Biotechnology
Volume: 6
Page: 17-33
Author(s): T. Kubik, K. Bogunia-Kubik and M. Sugisaka

Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation

Journal: Current Pharmaceutical Design
Volume: 11
Page: 395-401
Author(s): Kozo Yasui, Norimoto Kobayashi, Takashi Yamazaki and Kazunaga Agematsu

Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development

Journal: Current Pharmaceutical Design
Volume: 11
Page: 403-411
Author(s): Frank Entschladen, Theodore L. Drell IV, Kerstin Lang, Jan Joseph and Kurt S. Zaenker

The Clinical Genetics of Psoriasis

Journal: Current Genomics
Volume: 6
Page: 51-60
Author(s): E. Campalani and J. N.W.N. Barker

Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5
Page: 39-64
Author(s): Takanori Kawaguchi